These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 7905780

  • 1. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J.
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of generalized anxiety: new pharmacologic approaches].
    Boulenger JP.
    Encephale; 1995 Nov; 21(6):459-66. PubMed ID: 8674471
    [Abstract] [Full Text] [Related]

  • 4. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD.
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract] [Full Text] [Related]

  • 5. [Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs].
    Goffinet S.
    Ann Med Psychol (Paris); 1993 Jan; 151(1):47-63. PubMed ID: 7905724
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Future directions in anxiolytic pharmacotherapy.
    Kunovac JL, Stahl SM.
    Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The right drugs for panic and phobias. Managing anxiety in your patients].
    Stiefelhagen P.
    MMW Fortschr Med; 2001 Sep 13; 143(37):16. PubMed ID: 11599286
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pharmacotherapy with benzodiazepines: basic principles and new developments].
    Möhler H.
    Praxis (Bern 1994); 1998 Feb 04; 87(6):186-90. PubMed ID: 9531812
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E.
    J Clin Psychiatry; 2002 Feb 04; 63 Suppl 14():27-33. PubMed ID: 12562116
    [Abstract] [Full Text] [Related]

  • 16. Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder.
    Zwanzger P, Rupprecht R.
    J Psychiatry Neurosci; 2005 May 04; 30(3):167-75. PubMed ID: 15944741
    [Abstract] [Full Text] [Related]

  • 17. Benzodiazepine use, cognitive impairment, and cognitive-behavioral therapy for anxiety disorders: issues in the treatment of a patient in need.
    Otto MW, Bruce SE, Deckersbach T.
    J Clin Psychiatry; 2005 May 04; 66 Suppl 2():34-8. PubMed ID: 15762818
    [Abstract] [Full Text] [Related]

  • 18. The GABAA/benzodiazepine receptor: implications for the molecular basis of anxiety.
    Breier A, Paul SM.
    J Psychiatr Res; 1990 May 04; 24 Suppl 2():91-104. PubMed ID: 1980704
    [No Abstract] [Full Text] [Related]

  • 19. Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
    Chouinard G.
    J Clin Psychiatry; 2004 May 04; 65 Suppl 5():7-12. PubMed ID: 15078112
    [Abstract] [Full Text] [Related]

  • 20. The acute treatment of anxiety and depression.
    Swinson RP.
    Psychiatr J Univ Ott; 1989 Jun 04; 14(2):375-8; discussion 379-80. PubMed ID: 2569748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.